A practical approach is to identify fall risk, assess modifiable contributors, and intervene. Depending on the patient, this may include strength and balance work, medication review, vision and footwear assessment, home-safety measures, and management of conditions that affect gait or blood pressure.
Healthy Aging in Primary Care: When Routine Visits Cannot Fit Everything
A peer-level look at how family physicians and general practitioners manage the competing demands of older-adult visits, from cognition and mobility to medication risk, vaccination, functional decline, and digital workflow support.
Audience: Family Physicians / General Practitioners
Countries: 6
Completion Rate: 74.8%
SGID: 8946574
-Hero findings
– Quick Read — Key Findings
34.8%
Allocate more than 20 minutes
The largest visit-duration group already spends more than 20 minutes on routine wellness or chronic-care visits for patients aged 65+.
22.7%
Put mobility and fall risk second
Strength, balance, and gait assessment rank behind medication risk but ahead of cognition, immunization, nutrition, and frailty as the top single priority.
34.3%
Keep routine screening physician-led
The most common model is still screening performed entirely by the physician during the consultation.
31.7%
Use assistants or nurses before entry
Pre-screening is nearly as common as physician-only screening, suggesting a second pathway for distributing older-adult assessment work.
37.5%
Make medication decisions shared
Patient and caregiver involvement outranks dedicated review visits, pharmacist review, and structured tools as the most effective polypharmacy strategy.
30.4%
Favor EHR-integrated decision support
Clinical decision support for screening and deprescribing narrowly leads ambient scribes as the digital tool with the greatest perceived potential.
When one routine visit has to cover everything, what gets left behind?
Healthy aging asks primary care to cover many domains at once
The challenge is not identifying relevant domains. It is turning a broad, person-centred agenda into something that can reliably happen inside everyday primary care.
WHO’s 2025 Integrated Care for Older People guidance and the Age-Friendly Health Systems 4Ms framework (What Matters, Medication, Mentation, Mobility) make the same operational point: healthy aging is multi-domain by design, not a sequence of isolated disease checks.
The MDForLives survey sits inside that reality, asking family physicians and general practitioners how long routine visits take, what they prioritize, what they struggle to cover, and which workflows and digital tools might create more capacity.
Finding 1
Longer visits do not fix the capacity problem
34.8% allocate more than 20 minutes to routine wellness or chronic-care visits for patients aged 65+, while 32.3% report 16–20 minutes.
The largest group already runs past 20 minutes and 32.3% sit at 16–20, yet consultation time is still the dominant barrier to cognitive screening later in the survey. Even with a third of clinicians over 20 minutes, 48.3% in Finding 3 name visit time as their top barrier, so the real constraint is the number of domains competing for the visit, not the minutes on the calendar. When medication, gait, cognition, vaccination, nutrition, and what matters most can all be relevant in one encounter, even a longer slot feels compressed.
Medication wins on priority, cognition loses on time
36.3% rank polypharmacy and deprescribing as the single highest priority, but 39.0% say cognitive screening and dementia evaluation are the hardest healthy-aging domain to address adequately.
Medication risk is the most selected top priority, followed by mobility and fall risk at 22.7%, while cognition is a top priority for only 13.9% yet the clear leader in difficulty at 39.0% (medication review is second-hardest at 21.9%). That inversion is the real signal: the domains most at risk of being squeezed out are not the least important, but the ones that demand the most uninterrupted conversational and interpretive time. Medication decisions can anchor to a concrete list; cognitive assessment needs sensitive conversation, collateral history, and planning after a positive concern.
The cognitive-screening barrier is operational, not technological
48.3% identify insufficient consultation time as the primary barrier to conducting routine cognitive screening in older adults.
Consultation time leads by a wide margin, with patient or family resistance at 17.5%, specialist access 12.7%, lack of concise tools 12.4%, and limited action after diagnosis 9.2%. The barriers a new product would solve are minor next to time, so the finding argues for redesigning the visit rather than adding an instrument, and it aligns with Finding 5, where 31.7% already pre-screen with the team. It should not be read as a call for indiscriminate testing: the USPSTF finds insufficient evidence for universal screening of asymptomatic older adults, so this reflects what makes assessment difficult when clinicians judge it warranted.
Early decline often shows up first as lost complexity
33.7% say new difficulty with complex daily tasks such as medication management or finances most often goes unnoticed by patients and families.
Difficulty with complex daily tasks leads at 33.7%, ahead of muscle or grip loss at 24.4%, slower gait or balance at 21.0%, fatigue or social withdrawal at 13.0%, and weight loss or appetite change at 7.9%. The most-missed signals are functional, while the classic red flag of weight loss is missed least, so early decline tends to hide as lost capability rather than an obvious symptom. Medication errors, missed bills, a weaker grip, or a slower gait may each look minor alone, but together they can signal declining reserve, which is why asking what has become harder since the last visit can catch what a symptom-led review misses.
The work is shared, but the physician stays central
34.3% say routine geriatric screening is conducted entirely by the physician, while 31.7% use medical assistants or nurses to pre-screen before physician entry.
Physician-only screening (34.3%) and team pre-screening (31.7%) are nearly tied, with self-assessment at 10.6%, referral at 8.3%, and 15.1% who screen only when acute symptoms appear, the reactive group to watch. Task-sharing is already about a third of practice, but the judgment stays in the physician-patient conversation, a pattern medication management echoes: 37.5% credit shared decision-making with patients or caregivers, ahead of dedicated review visits (28.5%), pharmacist review (23.1%), and structured tools (10.9%). The tool matters, but the decision still has to make sense to the person taking the medicine.
Clinicians value digital tools that make room for decisions
30.4% select EHR-integrated clinical decision support as the digital or AI tool with the greatest potential to improve healthy-aging management over the next two to three years.
EHR decision support (30.4%) narrowly leads ambient scribes (28.5%), followed by pre-visit questionnaires (22.4%) and remote monitoring or wearables (18.6%). The top two take nearly 59% and both hand time back inside the workflow, while the option that adds a data stream to monitor ranks last. Immunization reinforces the point: a proactive recommendation during the consultation leads at 38.3%, ahead of EHR alerts (24.4%), standing orders (18.6%), and dedicated clinics (18.6%), so the preference is for technology that protects the visit and surfaces the next decision rather than one that generates more to watch.
Healthy aging is becoming a capacity-design problem
The survey does not show clinicians struggling to recognize that older-adult care is complex; it shows them making trade-offs inside that complexity. Polypharmacy is the most common top priority, cognition the hardest domain to fit, and consultation time the leading barrier to cognitive screening. Functional decline may first appear in complex daily tasks, screening stays largely physician-led even as team pre-screening grows, and the digital tools with the strongest appeal are the ones that reduce workflow burden or put decision support into the EHR.
The open-ended responses point the same way: clinicians repeatedly call for more time, longer appointments, home visits, social work, and stronger community and geriatric support. These are not requests for another checklist but for a care model that connects the clinic to the patient’s function at home and distributes work across a wider team.
Endocrinology, Diabetes & Metabolism
7Oncology & Hematology
7Hospital Administration
6Primary Care & Family Medicine
6Dermatology
6Ophthalmology
6Gastroenterology & Hepatology
6Dentistry & Oral Health
5Surgery & Procedural Care
5Pharmacy
5Pediatrics
5Neurology
5Nurses, NPs & Physician Assistants
4
Cardiology
4Radiology & Imaging
3Laboratory & Diagnostics
3Optometry & Optical Care
3Diabetes, Weight & Metabolic Health
3Cancer Care
1Skin & Aesthetic Care
1Social Work & Patient Support
1
You have read the summary
The findings go deeper.
So can your participation.
Frequently asked questions
Common practical questions about older-adult assessment, cognition, medication safety, mobility, and prevention.
What does healthy aging mean in primary care?
Healthy aging focuses on maintaining the functional ability that supports well-being and independence as people age. In primary care, that usually means looking beyond single diseases to medication safety, cognition, mobility, nutrition, prevention, social needs, and what matters most to the older adult.
What should primary care assess during visits with older adults?
The exact assessment depends on the patient and local guidance, but common priorities include medication review, mobility and fall risk, cognition when concerns arise, vaccination status, nutrition, functional ability, mood, sensory problems, and social support.
How should cognitive concerns be assessed in older adults?
Clinicians should evaluate cognitive concerns when symptoms, family observations, functional change, or other clinical signals raise concern. Recommendations on routine screening of asymptomatic adults vary by country; in the United States, the USPSTF currently states that evidence is insufficient to recommend for or against universal screening.
What is deprescribing in older adults?
Deprescribing is a structured, supervised process of reducing or stopping medicines when potential harms, burden, duplication, or limited benefit outweigh the expected value. It should be individualized and supported by shared decision-making rather than treated as an automatic medication cut.
How can primary care reduce fall risk in older adults?
Which vaccinations are important for older adults?
Vaccination recommendations vary by country, age, medical history, and risk. Common older-adult schedules may include influenza, pneumococcal, shingles, COVID-19, and RSV vaccination for eligible groups. Clinicians should use the current schedule for their country and the individual patient.
Direct answers to the questions healthcare professionals are most likely to ask about these findings.
Related Reports


Hospital Patient Experience: Where the Care Journey Still Breaks Down
